?ther THERAPEUTICS is thrilled to announce Aaron Scuchart as our new President & CEO! With over 25 years of?leadership?experience, Aaron has a proven track record?building biopharma businesses in operational and strategic roles with many?successful capital raises and strategic transactions. His leadership is set to drive our mission of breaking the chains of opioid addiction to new heights.
关于我们
The statistics are overwhelming: more than 130 people a day die from opioid related drug overdoses. In 2020 in the US alone, 2.7 million people aged 12 or older had Opioid Use Disorder (OUD) and 4.2 million people entered a drug rehabilitation program. While treatment programs and rescue medications are critical, ?ther THERAPEUTICS is focusing our efforts upstream: preventing addiction and creating a more effective treatment of OUD. ?ther THERAPEUTICS' main candidate is Low Dose 6β-Naltrexol (ATX-001). Animal models indicate that ATX-001 may prevent opioid dependence while not blocking pain relief or causing withdrawal & other adverse effects. Our vision is a world where the devastating effects of opioid addiction are alleviated, leading to: ? Safer opioid pain therapy without the fear of addiction, ? Cessation of opioid addiction ? Prevention of Neonatal Opioid Withdrawal Syndrome (NOWS) ?ther THERAPEUTICS is focused on our vision, driven by innovation, embraces lean operations and engaged with urgency.
- 网站
-
https://www.aethertherapeutics.com
?ther THERAPEUTICS的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Austin，Texas
- 类型
- 私人持股
- 创立
- 2017
- 领域
- Opioid Addiction, Dependence & Prevention
地点
-
主要
获取路线
4200 Marathon Blvd
Suite 200
US，Texas，Austin，78756
?ther THERAPEUTICS员工
动态
-
Last Call: Investment Window Closes Friday @ 9:00pm PST If you haven't already, please join our cause of Breaking the Chains of Opioid Addiction. Investments as little as $100 are welcome and will help us advance our groundbreaking technology! https://lnkd.in/gk8BmDD9?
-
?? Invest in the Future of Addiction Treatment with Aether THERAPEUTICS ?? Have you ever wondered what you can do to solve the opioid crisis? Aether THERAPEUTICS is on a mission to break the chains of opioid addiction with our groundbreaking compound, Low Dose 6β-Naltrexol (LD-6βN). Our innovative approach: - Non-Addictive Pain Management: Redefine pain treatment without the risk of addiction. - Addiction Rehabilitation: Catalyze addiction recovery for those battling addiction. - Prevent Neonatal Opioid Withdrawal Syndrome (NOWS): Provide a safer start for newborns. We're not just developing treatments; we're pioneering a new era in medical therapy. Join us in this transformative journey by investing in our equity crowdfunding campaign. ?? Explore the opportunity: https://lnkd.in/gk8BmDD9 ?? Why Invest? - Advance development of a solution that can directly benefit people in your circle. - Support cutting-edge research with real potential for societal change. - Opportunity for financial returns alongside making a difference. Let's build an addiction free future together. Invest now in Aether THERAPEUTICS. #AetherTherapeutics #InnovationInHealthcare #EquityCrowdfunding #InvestInHealth #AddictionRecovery #PainManagement
-
One thing we can all agree on ... The opioid crisis needs better tools with an upstream solution. aether THERAPEUTICS is advancing technology, backed by strong pre-clinical data, that has the promise to be a strong tool. Our approach attacks addiction upstream with our novel mechanism of action: Retrograde Addiction Modulator. https://lnkd.in/gdc7g2GZ?
Aether THEREAPEUTICS: Developing a weapon to treat the opioid crisis
https://www.youtube.com/
-
We are delighted to be a part of this live event and would welcome anyone who would like to know more about the pre-clinical models informing our novel mechanism of action - retrograde addiction modulator. Join me and our Chief Science Officer, Dr. Wolfgang Sadee. John.
?? You’re Invited to our Live Q&A ?? Join us for a live event with ?ther THERAPEUTICS on Tuesday October 29th at 7 pm ET, where their team will share their latest news and answer your questions. ?ther THERAPEUTICS aims to break the chains of opioid addiction by developing a drug that may prevent opioid dependence while not blocking pain relief or causing withdrawal or other adverse effects. ??Register for the Live Q&A here: https://hubs.li/Q02V-pJV0 ??And view their offering on Netcapital here: https://hubs.li/Q02V-pjC0
-
Monkey Business ... Preliminary Results in a primate model suggest that ATX-001 (6b-Naltrexol) suppresses drug craving at extremely low doses. We are committed to advancing ATX-001 and welcome your support and investment in aether THERAPEUTICS. Our Netcapital offering page provides more details on our technology, the company, and our robust pre-clinical data (including the preliminary primate model). Together, we can break the chains of opioid addiction. https://lnkd.in/gk8BmDD9?
-
I am delighted to announce that ?ther THERAPEUTICS is working with Netcapital, one of the leading Regulation Crowdfunding platforms in the industry.??ther THERAPEUTICS’ Netcapital Offering Page has officially gone live! https://lnkd.in/gk8BmDD9 Opioid addiction touches so many lives?- we believe that crowdfunding is a perfect vehicle for impact investment; enabling many people who have been affected by the opioid crisis to invest in a potential solution with an opportunity for a financial return.
-
The statistics of opioid addiction are overwhelming. Chances are, you, one of your loved ones or your friends have impacted by opioid addiction. - More than 130 people a day die from opioid related drug overdoses in the US. - 2.7 million people aged 12 or older suffered from Opioid Use Disorder (OUD) in the US (2020), and - 4.2 million people entered a drug rehabilitation program in the US (2020). ? ?ther THERAPEUTICS was founded in 2017 with a vision of Breaking the Chains of Opioid Addiction. Our founder - Wolfgang Sadee, PhD – is a recognized leader in opioid pharmacology. We have made significant progress over the last year, completing our pre-clinical testing. We are rolling up our sleeves and working towards engagement with the FDA to plan clinical trials.? ? This is a pivotal time for ?ther THERAPEUTICS, and we will have exciting news to share with you shortly.? ? Feel free to forward this to anyone in your circle – someone you know that has been impacted by opioids. Together we can make a difference! ? Your questions, comments and support are more than welcome!
-
-
Opioid addiction is heartbreaking. The chains of opioid addiction are too weak to be felt until they are too strong to be broken.? ? ?ther THERAPEUTICS fervently dedicated to?Breaking the Chains of Opioid Addiction?and we are excited to share exciting developments in the coming week! ? Keep your eyes peeled for follow-up posts AND feel free to message me directly! Stay Tuned,? John
-